Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eisai Ltd ADR (OP:ESALY)

N/A UNCHANGED
Last Price Updated: 3:59 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eisai Ltd ADR

< Previous 1 2 3 4 5 6 7 Next >
News headline image
What This Label Expansion Means for Merck ↗
The Keytruda-Lenvima combo was recently approved for its second oncology indication. 
Via The Motley Fool
News headline image
White House Dismisses Janet Woodcock As Permanent FDA Commissioner Candidate: Bloomberg ↗
The Biden Administration has ruled out the nomination of acting FDA commissioner Janet Woodcock as permanent head of the agency, Bloomberg reported citing people... 
Via Benzinga
News headline image
Controversial Aduhelm To Administered At More Than 300 Hospitals: Nikkei's ↗
Eisai Co Ltd (OTC: ESALY) and its U.S. partner Biogen Inc's (NASDAQ: BIIB) Alzheimer's treatment Aduhelm (aducanumab) will be used by more than 300... 
Via Benzinga
News headline image
The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among... 
Via Talk Markets
Topics Initial Public Offering
News headline image
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-... 
Via Benzinga
Topics Initial Public Offering
News headline image
Biogen's New Alzheimer's Drug Turned Away By Veterans Affairs ↗
The Department of Veterans Affairs (VA) has decided not to include the new Alzheimer's drug developed by Biogen Inc (NASDAQ: BIIB) and Eisai Co Ltd (OTC:... 
Via Benzinga
News headline image
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates ↗
The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
News Overload ↗
Today US markets managed a rally despite misses in both the growth and employment data. 
Via Talk Markets
News headline image
Full News Day ↗
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier. 
Via Talk Markets
Topics Energy
News headline image
Analysis Shows Biogen-Eisai's Aduhelm Slows Cognitive, Functional Decline In Early Alzheimer's Patients ↗
An analysis of Phase 3 data presented by Biogen Inc (NASDAQ: BIIB) and Eisai Co Ltd (OTC: ESALY) of its Alzheimer's therapy Aduhelm (aducanumab) ... 
Via Benzinga
News headline image
Containment Plan ↗
Today the US decided to cut China risks. 
Via Talk Markets
News headline image
Joblessness Surprise ↗
Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical... 
Via Benzinga
News headline image
“Claw-Back” day ↗
The rally was just as irrational as the selloff. 
Via Talk Markets
News headline image
Delta Defeats Bulls ↗
Stocks tended to crash without rhyme or reason. 
Via Talk Markets
News headline image
Weak Week ↗
Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism. 
Via Talk Markets
News headline image
Biogen's Alzheimer's Drug Aduhelm Review Could Have Been Handled Differently, Says FDA Chief: STAT News ↗
Acting FDA Commissioner Janet Woodcock pushed back against media questions about the agency's controversial approval of Alzheimer's treatment, Aduhelm developed by ... 
Via Benzinga
News headline image
Dialing For Stocks ↗
Thanks to Fed Chairman Powell, markets brushed off worrying about inflation today. 
Via Talk Markets
Topics Economy
News headline image
FDA Narrows Label To Recommend Use Of Biogen's Aduhelm In Mild Alzheimer's Patients ↗
Biogen Inc. (NASDAQ:BIIB) shares are lower after the compa... 
Via Benzinga
News headline image
People Needed ↗
If qualified people are not looking for work, they will have to be lured to do so with higher wages. 
Via Talk Markets
News headline image
End Of June ↗
Canadian Solar fell 4.6% on fears of plans for a China IPO where its panels are made. 
Via Talk Markets
Topics Initial Public Offering
News headline image
Summer Friday ↗
The stock market tried for another record after yesterday's late blowout over the infrastructure deal. 
Via Talk Markets
News headline image
Crazy Thursday ↗
Today the US stock market went ballistic probably because of a higher joblessness level than expected. 
Via Talk Markets
News headline image
Wednesday Is A Normal Day ↗
Meme stocks Gamestop and Torchlight Energy both did share sales to cash in on their share price rises. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
News headline image
The First Day Of Summer And Prime Day ↗
The bull is back in business today. 
Via Talk Markets
News headline image
3 More Reasons Biogen's Alzheimer's Drug Will Underperform Wall Street Expectations ↗
Beyond its lofty price tag, there are other impediments to big sales of aducanamab that the market largely ignored this week. 
Via The Motley Fool
News headline image
Did This Company Just Win Big Because of Biogen? ↗
Alzheimer's disease patients who take Aduhelm will need a lot of diagnostic scans, too. Imaging leader RadNet stands to benefit. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.